Citeline

citeline.com · Londonderry County Borough, United Kingdom

Citeline is a life sciences data and analytics company that provides clinical trial intelligence, drug development pipelines, and real‑world evidence solutions to pharmaceutical, biotech, and healthcare organizations. It aggregates and curates global clinical, regulatory, and commercial data into subscription platforms and data feeds that support R&D strategy, competitive intelligence, and go‑to‑market planning. The company generates revenue primarily through SaaS subscriptions, data licensing, and related analytics services.

Revenue
$350.0M
Employees
1,500
Founded
2003
Headquarters
Londonderry County Borough, United Kingdom

What 21 Arbolus experts think of Citeline

NPS distribution is heavily positive, with most scores in the 7–10 range and multiple perfect 10s, reflecting broad user satisfaction. Renewal intent is strong, with over 85% of relevant respondents planning to renew, although a small minority express uncertainty or reluctance, often linked to integration and operational overhead. Stickiness is high, as most users report being in the More Than 1 Year implementation stage and cite increased reliance on Citeline for strategic functions. Key expert themes highlight trust in data quality, competitive coverage, and integration fit as major strengths, while some weaknesses include workflow integration challenges and occasional need to normalize findings.Overall Customer Sentiment: Positive

Who reviewed Citeline

Total customers 21 19 current · 2 former
Reviews growth +11 in six months
Seniority of respondents
  • C-Suite 57% (12)
  • Director 29% (6)
  • Manager 14% (3)
Marketing Leader C-Suite NPS 10
Generalist Leader C-Suite NPS 8 Will renew
Revenue Partner Director NPS 8 Will renew

Employer names and spend open in the full report, along with the other 18 customers.

Everything 21 customers told us about Citeline.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

42 Net Promoter Score, from 21 scored reviews
  • Promoters 9
  • Passives 12
  • Detractors 0

Cumulative NPS by month

+0 over 6 months
  • Feb 8
  • Apr 8
  • May 8
  • Jun 8
  • Jul 8
  • Sep 8

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 34 across 2 companies.

Praised

  • Expansion Tied to Measurable Outcomes
  • AI-Driven Workflow Enhancement
  • Utilization-Based Spend Incentives
  • Reduction of Research Time

Criticised

  • Dependence on Support and Commercial Stability
  • Manual Normalization Required
  • Workflow Integration Challenges
  • Commercial and Support Disruption Risk

What customers say

Reduction of Research Time
“Screening therapeutic-area pipelines in Citeline has reduced our research time and improved the quality of our opportunity shortlists.”
Early Identification of Market Shifts
“Monitoring competitor trials and milestones in Citeline has helped our teams identify market changes earlier and prepare more focused strategic reviews.”
Depth of Pharmaceutical Intelligence
“I rely on Citeline for its deep pharmaceutical intelligence, trial context, and competitive landscape coverage, which are essential to our workflows.”

Renewal intent

Plan to renew 71%
  • Will renew 10
  • Undecided 3
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 63% 8 answers
  • Director 75% 4 answers
  • Manager 100% 2 answers
  • 8.2/10 Average score from customers who will renew
  • 7.7/10 Average score from undecided customers
  • 9/10 Average score from customers not renewing

Top alternatives

Most weighed by Citeline customers

Report

For people who use Citeline

Do you use Citeline at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 21 customers of Citeline have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.